Literature DB >> 17275668

Neonatal subependymal giant cell astrocytoma: new case and review of literature.

G Praveen Raju1, David K Urion, Mustafa Sahin.   

Abstract

Subependymal giant cell astrocytomas are one of the three major intracranial lesions found in tuberous sclerosis complex. Subependymal giant cell astrocytomas are typically slow-growing tumors of mixed glioneuronal lineage which can become aggressive and cause obstructive hydrocephalus usually in older children and adolescents. Neonatal subependymal giant cell astrocytomas are extremely rare, and their natural history and prognosis are poorly understood. This report investigates an extremely large neonatal subependymal giant cell astrocytoma which was initially identified in utero at 19 weeks of gestation in a high-risk pregnancy with no family history of tuberous sclerosis complex.

Entities:  

Mesh:

Year:  2007        PMID: 17275668     DOI: 10.1016/j.pediatrneurol.2006.08.009

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  16 in total

1.  Fetal brain lesions in tuberous sclerosis complex: TORC1 activation and inflammation.

Authors:  Avanita S Prabowo; Jasper J Anink; Martin Lammens; Mark Nellist; Ans M W van den Ouweland; Homa Adle-Biassette; Harvey B Sarnat; Laura Flores-Sarnat; Peter B Crino; Eleonora Aronica
Journal:  Brain Pathol       Date:  2012-08-30       Impact factor: 6.508

2.  Congenital tumors of the central nervous system.

Authors:  Mariasavina Severino; Erin S Schwartz; Majda M Thurnher; Jana Rydland; Ioannis Nikas; Andrea Rossi
Journal:  Neuroradiology       Date:  2010-04-29       Impact factor: 2.804

Review 3.  Neurosurgical treatment of tuberous sclerosis complex lesions.

Authors:  Ignacio Pascual-Castroviejo
Journal:  Childs Nerv Syst       Date:  2011-05-24       Impact factor: 1.475

4.  Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex.

Authors:  Darcy A Krueger
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

Review 5.  TSC1/TSC2 signaling in the CNS.

Authors:  Juliette M Han; Mustafa Sahin
Journal:  FEBS Lett       Date:  2011-02-15       Impact factor: 4.124

Review 6.  Management of subependymal giant cell tumors in tuberous sclerosis complex: the neurosurgeon's perspective.

Authors:  Moncef Berhouma
Journal:  World J Pediatr       Date:  2010-05-21       Impact factor: 2.764

7.  Recommendations for the radiological diagnosis and follow-up of neuropathological abnormalities associated with tuberous sclerosis complex.

Authors:  Àlex Rovira; María Luz Ruiz-Falcó; Elena García-Esparza; Eduardo López-Laso; Alfons Macaya; Ignacio Málaga; Élida Vázquez; Josefina Vicente
Journal:  J Neurooncol       Date:  2014-04-27       Impact factor: 4.130

Review 8.  Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.

Authors:  Jeffrey P MacKeigan; Darcy A Krueger
Journal:  Neuro Oncol       Date:  2015-08-19       Impact factor: 12.300

Review 9.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

10.  Congenital subependymal giant cell astrocytoma: clinical considerations and expression of radial glial cell markers in giant cells.

Authors:  Ji Hoon Phi; Sung-Hye Park; Jong Hee Chae; Ki Ho Hong; Sung Sup Park; Ji Hyun Kang; Jong Kwan Jun; Byung-Kyu Cho; Kyu-Chang Wang; Seung-Ki Kim
Journal:  Childs Nerv Syst       Date:  2008-07-16       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.